Literature DB >> 8717385

Improved method for the removal of endotoxin from DNA.

P M Montbriand1, R W Malone.   

Abstract

Contaminating endotoxin in solutions used in gene therapy and genetic immunization can result in various deleterious effects both in vitro and in vivo. In order to avoid such complications, attempts were made to characterize the extent of the problem of endotoxin contamination and develop a solution to this problem. After screening for endotoxin in plasmid DNA preparations using the Limulus Amoebocyte Lysate (LAL) assay, nearly half of all samples displayed high endotoxin levels. Therefore, a simple one-step procedure was developed for the removal of endotoxin using a polymyxin B resin.

Mesh:

Substances:

Year:  1996        PMID: 8717385     DOI: 10.1016/0168-1656(95)00091-7

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  3 in total

1.  Non-GMP plasmid production for transient transfection in bioreactors.

Authors:  G Schmid; E J Schlaeger; B Wipf
Journal:  Cytotechnology       Date:  2001-05       Impact factor: 2.058

2.  In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.

Authors:  G A Brazeau; S Attia; S Poxon; J A Hughes
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

3.  Good Manufacturing Practices production and analysis of a DNA vaccine against dental caries.

Authors:  Ya-ping Yang; Yu-hong Li; Ai-hua Zhang; Lan Bi; Ming-wen Fan
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.